Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Kestra Medical Technologies CFO Vaseem Mahboob Sells $2.41M of Stock
Vaseem Mahboob, CFO, sold 79,500 shares of Kestra Medical Technologies, Ltd. at $30.04 to $30.60 a share (average $30.30) in 3 transactions, worth $2.41M in total between Oct 27, 2026 and Oct 29, 2026. Shares held after the trade: 60,609 (-7.3%).
John Bicket sold 263,900 shares of Samsara Inc. at $41.45 to $44.97 a share (average $42.92) in 13 transactions, worth $11.3M in total between Oct 27, 2026 and Oct 29, 2026. Shares held after the trade: 561,398 (-2.3%).
Kestra Medical Technologies Insider Traci S. Umberger Sells $901K of Stock
Traci S. Umberger sold 30,000 shares of Kestra Medical Technologies, Ltd. at $30.03 a share, worth $901K in total on Oct 27, 2026. Shares held after the trade: 195,825 (-13.3%).
Apple SVP, GC and Government Affairs Jennifer Newstead Sells $824K of Stock
Jennifer Newstead, SVP, GC and Government Affairs, sold 2,399 shares of Apple Inc. at $343.36 a share, worth $824K in total on Oct 27, 2026. Shares held after the trade: 32,396 (-6.9%).
Keycorp Head of Institutional Bank Andrew J. Paine III Sells $830K of Stock
Andrew J. Paine III, Head of Institutional Bank, sold 39,130 shares of Keycorp at $21.20 a share, worth $830K in total on Oct 28, 2026. Shares held after the trade: 191,571 (-17.0%).
Twilio delivered record Q3 revenue and profitability, driven by 16% organic growth and strong voice/software add-on adoption, while raising full-year 2026 guidance and providing a robust preliminary 2027 outlook.
Boundless Bio 10% Owner Kevin Tang Buys $25.7K of Stock
Kevin Tang, 10% Owner, bought 10,707 shares of Boundless Bio, Inc. at $2.40 a share, worth $25.7K in total on Oct 27, 2026. Shares held after the trade: 3,022,456 (+0.4%).
Sierra Bancorp Insider Lynda Scearcy Sells $248K of Stock
Lynda Scearcy sold 5,850 shares of Sierra Bancorp at $42.34 a share, worth $248K in total on Oct 29, 2026. Shares held after the trade: 24,283 (-19.4%).
Floor & Decor delivered 11% adjusted EPS growth despite a 1.4% comparable sales decline, while announcing a significant moderation in 2027 store expansion plans due to persistent macroeconomic headwinds.
Sierra Bancorp President/CEO Kevin J. McPhaill Sells $171K of Stock
Kevin J. McPhaill, President/CEO, sold 4,000 shares of Sierra Bancorp at $42.85 a share, worth $171K in total on Oct 29, 2026. Shares held after the trade: 63,807 (-5.9%).
Lindblad Expeditions Holdings Director Sven-Olof Lindblad Sells $8.25M of Stock
Sven-Olof Lindblad, Director, sold 230,197 shares of Lindblad Expeditions Holdings, Inc. at $35.16 to $37.19 a share (average $35.86) in 6 transactions, worth $8.25M in total between Oct 27, 2026 and Oct 29, 2026. Shares held after the trade: 9,937,202 (-0.2%).
Ingram Micro delivered record Q3 results with 21% revenue growth, driven by a 160% surge in AI infrastructure and GPU sales, leading to raised full-year guidance.
HP Pres Imaging Prtng & Solutions Anneliese Olson Sells $619K of Stock
Anneliese Olson, Pres Imaging Prtng & Solutions, sold 18,997 shares of HP Inc at $32.56 a share, worth $619K in total on Oct 29, 2026. Shares held after the trade: 169 (-99.1%).
BridgeBio is transitioning to a multi-product commercial stage company with $253.2M in Acaramidus revenue and three major FDA PDUFA dates scheduled within the next seven months.
Enova International Chief Strategy Officer Kirk Chartier Sells $4.8M of Stock
Kirk Chartier, Chief Strategy Officer, sold 27,977 shares of Enova International, Inc. at $171.51 a share, worth $4.8M in total on Oct 27, 2026. Shares held after the trade: 76,995 (-26.7%).
Enova International Executive Chairman David Fisher Sells $4.04M of Stock
David Fisher, Executive Chairman, sold 23,157 shares of Enova International, Inc. at $171.79 to $178.16 a share (average $174.53) in 2 transactions, worth $4.04M in total between Oct 27, 2026 and Oct 28, 2026. Shares held after the trade: 306,444 (-3.1%).
Enova International CEO Steven E. Cunningham Sells $2.63M of Stock
Steven E. Cunningham, CEO, sold 15,305 shares of Enova International, Inc. at $172.00 a share, worth $2.63M in total on Oct 27, 2026. Shares held after the trade: 118,789 (-3.4%).
New Germany Fund Insider Saba Capital Management L.P. Buys $25.5K of Stock
Saba Capital Management L.P. bought 2,504 shares of New Germany Fund Inc at $10.20 a share, worth $25.5K in total on Oct 28, 2026. Shares held after the trade: 3,903,924 (+0.1%).
Dime Commercial Bancshares Director Basswood Capital Management L.L.C. Sells $1.31M of Stock
Basswood Capital Management L.L.C., Director, sold 30,988 shares of Dime Commercial Bancshares, Inc. at $42.02 to $42.51 a share (average $42.42) in 10 transactions, worth $1.31M in total between Oct 27, 2026 and Oct 29, 2026. Shares held after the trade: 369,832 (-0.2%).
SkyWest delivered strong Q3 2026 results with $120M net income, navigating high fuel costs through strategic fleet transitions and robust pro-rate demand while maintaining a disciplined capital deployment strategy.
BNY Mellon Strategic Municipal Bond Fund Insider Saba Capital Management L.P. Buys $10.8K of Stock
Saba Capital Management L.P. bought 1,992 shares of BNY Mellon Strategic Municipal Bond Fund, Inc. at $5.43 a share, worth $10.8K in total on Oct 28, 2026. Shares held after the trade: 5,472,376 (+0.0%).
Japan Smaller Capitalization Fund Insider Saba Capital Management L.P. Buys $182K of Stock
Saba Capital Management L.P. bought 15,967 shares of Japan Smaller Capitalization Fund Inc at $11.38 a share, worth $182K in total on Oct 28, 2026. Shares held after the trade: 2,758,343 (+0.6%).
Estrella Immunopharma appointed Cynthia Pussinen as Chief Executive Officer and Chairperson of the Board, effective October 25, 2026. She succeeds Cheng Liu, Ph.D., who transitioned to the role of Chief Scientific Officer while remaining President and a director. Ms. Pussinen's employment agreement includes an initial base salary of $250,000 with automatic increases tied to future funding milestones.
T3 Defense Inc. raised $10 million in gross proceeds through a private placement of 200 units to an accredited investor. Each unit consists of one share of Series B Convertible Preferred Stock and warrants to purchase 14,851 shares of common stock. The company received net proceeds of approximately $6.6 million after deducting placement agent fees and the repayment of an existing term note.
Dermata Therapeutics announced the enrollment of the first participant in a clinical trial for Tome Clearing Treatment, its once-weekly acne treatment. The company expects to launch this product commercially in the first half of 2027 as part of its strategic shift toward skincare products.
CarParts.com achieved its third consecutive positive adjusted EBITDA quarter, signaling a successful shift toward a capital-light, higher-margin dropship model and recurring fee income.
American Coastal delivered a strong 64.7% combined ratio and 24% core ROE despite softening Florida commercial property rates and a 19.7 million revenue decline.
ADTRAN Holdings, Inc. has appointed Dr. Christian Terlinde to its Board of Directors, effective October 27, 2026, increasing the board size from seven to eight members. Dr. Terlinde, who currently serves as Group CFO of Flender International GmbH, joins as an independent director with extensive financial leadership experience in both U.S. and German markets.
Dine Brands Global, Inc. adopted a limited duration stockholder rights agreement (poison pill) in response to reports of significant open market accumulation of its stock. The plan issues one right per share of common stock, exercisable if a person or group acquires 10% (or 20% for passive investors) of the company's outstanding shares, and is set to expire on October 27, 2027.